Carrying the Likelihood-of-Approval Flag

Jun 20, 2018 | News

Recent research on clinical trial success rates that caught our eye: We are especially encouraged to see a group from MIT carrying forward the torch of drug likelihood-of-approval (LOA) analysis. That group of researchers put together this great analysis of what they...

Chart of the Week: Phase 3 LOA Vs Precision Medicine Score

Oct 24, 2016 | News

This week’s Chart of the Week attempts to communicate the correlation between a Company’s Precision Medicine Score and the Company’s Phase 3 Likelihood of Approval (LOA). This chart depicts how as a company increases their Precision Medicine Score, they...

Precision Medicine Innovation Not Just a Numbers Game

May 11, 2016 | News

We published a revision to our Precision Medicine Scorecard: Drug Company Edition last month. As John Audette rightfully notes, there are multiple factors in a pharmaceutical company’s contribution to precision medicines: How many precision medicines a company...

Chart of the Week: Celgene Precision Medicine Activities Graph

May 10, 2016 | News

We’ve been curious about Celgene’s activity in precision medicine for some time.  We’ve posted blog posts here, here and here proposing that Celgene’s activities are indicative of a precision medicine push.  As a supplement, this weeks CotW is...